Tg Therapeutics (TGTX) Gross Profit (2021 - 2025)
Historic Gross Profit for Tg Therapeutics (TGTX) over the last 5 years, with Q3 2025 value amounting to $133.6 million.
- Tg Therapeutics' Gross Profit rose 7925.89% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $453.9 million, marking a year-over-year increase of 9411.03%. This contributed to the annual value of $290.5 million for FY2024, which is 3233.58% up from last year.
- Per Tg Therapeutics' latest filing, its Gross Profit stood at $133.6 million for Q3 2025, which was up 7925.89% from $122.2 million recorded in Q2 2025.
- Tg Therapeutics' Gross Profit's 5-year high stood at $162.3 million during Q3 2023, with a 5-year trough of $77000.0 in Q4 2022.
- Moreover, its 5-year median value for Gross Profit was $61.6 million (2024), whereas its average is $62.3 million.
- Its Gross Profit has fluctuated over the past 5 years, first soared by 17631956.52% in 2023, then tumbled by 5407.56% in 2024.
- Quarter analysis of 5 years shows Tg Therapeutics' Gross Profit stood at $654000.0 in 2021, then tumbled by 88.23% to $77000.0 in 2022, then soared by 46805.19% to $36.1 million in 2023, then soared by 156.9% to $92.8 million in 2024, then skyrocketed by 44.0% to $133.6 million in 2025.
- Its Gross Profit was $133.6 million in Q3 2025, compared to $122.2 million in Q2 2025 and $105.3 million in Q1 2025.